Increasing prevalence of dehydration-related conditions, growing health and wellness trends, and aging population are the major factors which drive the global market growth. 

PORTLAND, Ore., Aug. 13, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Intravenous (IV) Hydration Therapy Market by Service (Immune boosters, Energy boosters, Skin care, Migraine and Others), Component (Medicated and Non-medicated), End user (Hospital & Clinics, Wellness Centers & Spas, Home Healthcare, and Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023, and is estimated to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Allied Market Research Logo

Request Sample of the Report on Intravenous (IV) Hydration Therapy Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A323708 

Prime determinants of growth  

Increasing prevalence of dehydration-related conditions, and growing health and wellness trends are the major factors that drive the growth of the intravenous (IV) hydration therapy market growth. However, high cost and risk of complications hinder the market growth. Moreover, technological advancements and expanding healthcare infrastructure in developing economies offers remunerative opportunities for the expansion of the global intravenous (IV) hydration therapy market. 

Report coverage & details

Report Coverage 

Details 

Forecast Period 

2024–2033 

Base Year 

2023

Market Size in 2023 

$2.3 billion 

Market Size in 2033 

$4.9 billion 

CAGR 

7.8 %

No. of Pages in Report 

220

Segments Covered 

Service, Component, End User and Region. 

Drivers 

Increase in prevalence of dehydration-related conditions 


Growth in health and wellness trends  


Rise in aging population 

Opportunities 

Technological advancements 


Increase in healthcare spending 

Restraints 

High cost 


Risk of complications 

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A323708 

Segment Highlights 

The immune booster service is widely used in the IV hydration therapy market due to its effectiveness in enhancing the body's natural defenses. This treatment typically includes a combination of vitamins, such as Vitamin C and B-Complex, along with essential minerals and antioxidants. By directly infusing these nutrients into the bloodstream, the therapy quickly boosts the immune system, helping to prevent illnesses and accelerate recovery, making it popular among health-conscious individuals. 

In addition, the rise in the use of medicated IV hydration therapy is fueled by its effectiveness in quickly replenishing essential nutrients and fluids. This therapy bypasses the digestive system, delivering vitamins, minerals, and medications directly into the bloodstream. It's popular among athletes, those seeking quick recovery from dehydration, and individuals aiming to boost energy levels or treat specific health conditions. Its convenience and immediate impact contribute to its growing popularity in wellness and medical circles. 

Have a Question? Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A323708 

Furthermore, the need for IV hydration therapy is prominently observed in hospitals and clinics where patients require rapid rehydration due to conditions such as severe dehydration, electrolyte imbalances, or inability to take fluids orally. IV therapy allows healthcare providers to deliver fluids, electrolytes, and medications directly into the bloodstream, ensuring efficient absorption and swift relief of symptoms. Its controlled administration and ability to address critical medical needs make it a cornerstone in clinical settings for managing various health challenges. 

Regional Outlook 

The IV hydration therapy market varies regionally. North America leads due to high health awareness, advanced healthcare, and disposable income. Europe follows with growing wellness tourism and dehydration treatment. The Asia-Pacific region is rapidly expanding due to rising health awareness and better healthcare access. Latin America and the Middle East are also growing, driven by improved healthcare and medical tourism, despite regulatory challenges and higher costs. 

Key Players

  • Davita
  • Nikkiso Co. Ltd.
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare
  • Baxter International Inc.
  • Drip Hydration

The report provides a detailed analysis of these key players in the global intravenous (IV) hydration therapy market. These players have adopted different strategies such as expansion, product approval, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Recent Industry Development

  • In December 2022, The DRIPBaR, an IV vitamin therapy franchise growing rapidly across America, announced that they have partnered with entrepreneur, investor, and original "Shark Tank" shark, Kevin Harrington. Providing cells with the nutritional "fuel" through IV therapy, the franchise is experiencing tremendous annual growth as well as rapidly expanding across the nation. 
  • In September 2021, B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced the launch of its new CARESAFE IV Administration Sets with Optional AirStop component. CARESAFE IV Sets are the first robust portfolio of IV administration sets in the U.S. market that are not made with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP). 
  • In September 2022, ScreenPro Security Inc.  announced that its wholly owned subsidiary Concierge Medical Consultants Inc. has introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/intravenous-iv-hydration-therapy-market-to-reach-4-9-billion-globally-by-2033-at-7-8-cagr-allied-market-research-302220897.html

Copyright 2024 PR Newswire